Journal of AIDS and HIV Research
Subscribe to JAHR
Full Name*
Email Address*

Article Number - 57A9BDA65779

Vol.9(9), pp. 187-193 , September 2017
ISSN: 2141-2359

 Total Views: 0
 Downloaded: 0

Full Length Research Paper

Determinant of mortality in HIV infected people on antiretroviral therapy in Southwest Ethiopia

Bedilu Girma Weji
  • Bedilu Girma Weji
  • Department of Anesthesia, College of Health Science and Medicine, Wolaita Sodo University, P. O. Box 138, Wolaita Sodo, SNNR, Ethiopia.
  • Google Scholar

 Received: 24 April 2017  Accepted: 29 June 2017  Published: 30 September 2017

Copyright © 2017 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0

The introduction of antiretroviral drug has considerably reformed the course of HIV/AIDS from life threatening epidemic to a chronic manageable health problem. Mortality and morbidity associated with HIV/AIDS are changing. The main aim of this study was to assess the potential determinant of death among people infected with HIV and initiated anti-retroviral therapy (ART). A general retrospective cohort method was used on 2655 people undertaking ART at Mizan Hospital from 7 January, 2005 to 8 May, 2013 in Southern Ethiopia. The three age groups: Pediatrics (age under 10 years), teens (age between 11 and 19 years), and elderly (age older than 20 years) was used to stratify the cohort. The usual clinical follow-up registry of the ART clinic was the main data for the study. Kaplan-Meier (KM) method was used to compare the survival experience of patients after initiation of ART. Cox proportional regression model was used to assess determinant of mortality. A total of 2655 patients, consisting of 6.3% pediatrics, 3.3% teenagers and 90.4% elderly were included in the study. The survival probability at the sixth month after initiation of the treatment was 96, 94, 96 and 96% for pediatrics, teenagers and adults, respectively. A low initial CD4 (P=0.001), advanced WHO clinical disease stage (P=0.01), receiving ISONIAZID preventive prophylaxis (P=0.02), tuberculosis coinfection (P < 0.001) and being bedridden (P < 0.002) was an independent determinant of death. The cumulative incidence of mortality rate for HIV patients has been low in this study hence early initiation of the treatment is highly recommended.

Key words: Anti-retroviral therapy, mortality, South Ethiopia.

AIDS Institute (2013). New York. 



Alemu AW, Sebastián MS (2010). Determinants of survival in adult HIV patients on antiretroviral therapy in Oromiyaa, Ethiopia. Glob. Health Action 3(1):5398.


Andreychyn M, Zhyvytsia D (2013). Effect of antiretroviral therapy on survival of HIV/TB-infected patients in Ukraine. Age 34(1):1.


Assefa T, Wencheko E (2012). Survival analysis of patients under chronic HIV-care and antiretroviral treatment at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. Ethiop. J. Health Dev. 26(1):22-29.


Bakanda C, Birungi J, Mwesigwa R, Nachega JB, Chan K, Palmer A, Ford N, Mills EJ (2011). Survival of HIV-infected adolescents on antiretroviral therapy in Uganda: findings from a nationally representative cohort in Uganda. PLoS One 6(4):e19261.


Biadgilign S, Reda AA, Digaffe T (2012). Predictors of mortality among HIV infected patients taking antiretroviral treatment in Ethiopia: A retrospective cohort study. AIDS Res. Ther. 9(1):15.


Cavanaugh JS, Shah NS, Cain KP, Winston CA (2012). Survival among Patients with HIV Infection and Smear-Negative Pulmonary Tuberculosis-United States, 1993-2006. PloS one 7(10):e47855.


Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, Godbole SV (2011). Prevention of HIV-1 infection with early antiretroviral therapy. N. Engl. J. Med. 365(6):493-505.


CSA-Ethiopia ICF (2011). 'International: Ethiopia Demographic and Health Survey 2011. 2012', Maryland, USA: Central Statistical Agency of Ethiopia and ICF International Addis Ababa, Ethiopia and Calverton.


Federal Democratic Republic of Ethiopia (2012). Country Progress Report on HIV/AIDS Response. In: The Planning Monitoring and Evaluation Directorate of the Federal HIV/AIDS Prevention and Control Office (HAPCO) (ed)). (2012). Addis Ababa. 


FMOH (2007). Implementation Guideline for TUBERCULOSIS / HIV Collaborative Activities in Ethiopia. 



Hanna DB, Buchacz K, Gebo KA, Hessol NA, Horberg MA, Jacobson LP, Kirk GD, Kitahata MM, Korthuis PT, Moore RD, Napravnik S (2013). Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009. Clin. Infect. Dis. 56(8):1174-1182.


Johnson LF, Mossong J, Dorrington RE, Schomaker M, Hoffmann CJ, Keiser O, Fox MP, Wood R, Prozesky H, Giddy J (2013). Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies. PLoS Med. 10(4):e1001418.


Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, Hogg RS, Deeks SG, Eron JJ, Brooks JT (2009). Effect of early versus deferred antiretroviral therapy for HIV on survival. N. Engl. J. Med. 360(18):1815-1826.


Ministry of Health (MOH) (2003). Guidelines for use of Antiretroviral drugs in Ethiopia. In: Disease Prevention and Control Department In collaboration with HIV/ AIDS Prevention and Control office (HAPCO) and Drug Administration and Control Authority (D (2003). Addis Ababa. 


Nachega JB, Hislop M, Nguyen H, Dowdy DW, Chaisson RE, Regensberg L, Cotton M, Maartens G (2009). Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa. J. Acquir. Immune Defic. Syndromes 51(1):65.


Organization WH (2012a). Antiretroviral treatment as prevention (TASP) of HIV and TUBERCULOSIS Programmatic update', Geneva: WHO.


Organization WH (2012b). The strategic use of antiretrovirals to help end the HIV epidemic'. World Health Organization.


Shaweno D, Worku A (2012). Tuberculosis treatment survival of HIV positive TUBERCULOSIS patients on directly observed treatment short-course in Southern Ethiopia: a retrospective cohort study. BMC Res. Notes 


Tsegaye E, Worku A (2011). Assessment of antiretroviral treatment outcome in public hospitals, South Nations Nationalities and Peoples Region, Ethiopia. Ethiop. J. Health Dev. 25(2):102-109.


Vitoria M, Granich R, Banda M, Fox MY, Gilks C (2010). Implementation of co-trimoxazole prophylaxis and isoniazid preventive therapy for people living with HIV. Bull. World Health Organ. 88(4):241-241.


World Health Organization (WHO) (2005). Demographic and socioeconomic data. J. Biosoc. Science. 


World Health Organization (WHO) (2012). World AIDS Day 2012: Closing in on global HIV targets. 



Zachariah R, Fitzgerald M, Massaquoi M, Pasulani O, Arnould L, Makombe S, Harries AD (2006). Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi. AIDS 20(18):2355-60.


Zaidi J, Grapsa E, Tanser F, Newell ML, Bärnighausen T (2013). Dramatic increase in HIV prevalence after scale-up of antiretroviral treatment. AIDS 27(14):2301.


APA Weji, B. G. (2017). Determinant of mortality in HIV infected people on antiretroviral therapy in Southwest Ethiopia. Journal of AIDS and HIV Research, 9(9), 187-193.
Chicago Bedilu Girma Weji. "Determinant of mortality in HIV infected people on antiretroviral therapy in Southwest Ethiopia." Journal of AIDS and HIV Research 9, no. 9 (2017): 187-193.
MLA Bedilu Girma Weji. "Determinant of mortality in HIV infected people on antiretroviral therapy in Southwest Ethiopia." Journal of AIDS and HIV Research 9.9 (2017): 187-193.

Subscription Form